Palash C. Maity

Ulm, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

IGLV3-21R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.

IGLV3-21R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.

Journal: HemaSphere
Published: December 05, 2025

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis.

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis.

Journal: Leukemia
Published: April 24, 2025

Facilitating Gene Editing in Human Lymphoma Cells Using Murine Ecotropic γ-Retroviruses.

Facilitating Gene Editing in Human Lymphoma Cells Using Murine Ecotropic γ-Retroviruses.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 03, 2025

GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migration.

GPR15LG binds CXCR4 and synergistically modulates CXCL12-induced cell signaling and migration.

Journal: Cell communication and signaling : CCS
Published: February 11, 2025

RNA binding protein Sam68 promotes germinal center reaction and IgG response through regulation of miR29.

RNA binding protein Sam68 promotes germinal center reaction and IgG response through regulation of miR29.

Journal: Cellular and molecular life sciences : CMLS
Published: January 12, 2025

CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma.

CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma.

Journal: International journal of molecular sciences
Published: November 27, 2024

Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1.

Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1.

Journal: Nature communications
Published: October 08, 2024

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands.

Journal: Leukemia
Published: March 04, 2024

A room-temperature gas sensor based on 2D Ni-Co-Zn ternary oxide nanoflakes for selective and sensitive ammonia detection.

A room-temperature gas sensor based on 2D Ni-Co-Zn ternary oxide nanoflakes for selective and sensitive ammonia detection.

Journal: Dalton transactions (Cambridge, England : 2003)
Published: October 25, 2023

Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation.

Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation.

Journal: Journal of leukocyte biology
Published: December 10, 2021

The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.

The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.

Journal: Frontiers in oncology
Published: September 06, 2021

B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.

B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.

Journal: The Journal of clinical investigation
Published: March 22, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026